0001477449-24-000043.txt : 20240305 0001477449-24-000043.hdr.sgml : 20240305 20240305160912 ACCESSION NUMBER: 0001477449-24-000043 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240301 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nanis Nikolaos P. CENTRAL INDEX KEY: 0002001935 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 24720388 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 wk-form4_1709672936.xml FORM 4 X0508 4 2024-03-01 0 0001477449 Teladoc Health, Inc. TDOC 0002001935 Nanis Nikolaos P. C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 0 1 0 0 Chief Technology Officer 0 Common Stock 2024-03-01 4 M 0 1479 A 66510 D Common Stock 2024-03-01 4 M 0 505 A 67015 D Common Stock 2024-03-01 4 M 0 894 A 67909 D Common Stock 2024-03-01 4 M 0 4340 A 72249 D Common Stock 2024-03-01 4 M 0 467 A 72716 D Common Stock 2024-03-04 4 S 0 2866 14.516 D 69850 D Performance Stock Units 2024-03-01 4 A 0 4437 0 A Common Stock 4437 4437 D Performance Stock Units 2024-03-01 4 M 0 1479 0 D Common Stock 1479 2958 D Restricted Stock Units 2024-03-01 4 M 0 505 0 D Common Stock 505 2023 D Restricted Stock Units 2024-03-01 4 M 0 894 0 D Common Stock 894 4472 D Restricted Stock Units 2024-03-01 4 M 0 4340 0 D Common Stock 4340 8681 D Restricted Stock Units 2024-03-01 4 M 0 467 0 D Common Stock 467 0 D Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Each performance stock unit represents a contingent right to receive one share of TDOC common stock. Performance award amount determined based on metrics in respect of the issuer's 2023 financial results. The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 1, 2024, the reporting person earned 4,437 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 1, 2022, the reporting person was granted 6,064 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. On June 1, 2022, the reporting person was granted 10,730 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 3, 2023, the reporting person was granted 13,021 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 2, 2021, the reporting person was granted 1,400 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. /s/ Adam C. Vandervoort, Attorney-in-Fact 2024-03-05